There is an error in [Table 2](#pone.0135432.t001){ref-type="table"}. The trial name, WHI II Prempro, in the ninth row is incorrect. The correct trial name is: WHI II Premarin. Please see the correct [Table 2](#pone.0135432.t001){ref-type="table"} here.
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###### Percent screened Peri/Postmenopausal Women Diagnosed with 1st Incident Invasive Breast Cancer in 19 published Studies.
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  \#       Trial                                                     Number of Women                      Baseline Age   Years Studied   Number with Breast Cancer   Incidence \[Percent\]
  -------- --------------------------------------------------------- ------------------------------------ -------------- --------------- --------------------------- -----------------------
  **1**    UK Million Women Study \[18\]                             **1,084,110**                        **50--64**     **2.6**         **9364**                    **0.86%**
  **2**    Danish Nurses Health \[19\]                               **10,874**                           **\>44**       **6**           **244**                     **2.24%**
  **3**    Melbourne Postmenopausal \[20\]                           **13,444**                           **40--69**     **10**          **336**                     **2.50%**
  **4**    Finnish Registry ERT \[21\]                               **110,980**                          **\>50**       **8**           **2171**                    **1.96%**
  **5**    Finnish Registry E&P \[22\]                               **221,551**                          **\>50**       **11**          **6211**                    **2.80%**
  **6**    French Cohort \[23\]                                      **3175**                             **\>50**       **13**          **105**                     **3.31%**
  **7**    WHI I Prempro \[24\]                                      8506                                 **50--79**     **5.2**         **166**                     **1.95%**
  **7**    WHI I Placebo \[24\]                                      8102                                 **50--79**     **5.2**         **124**                     **1.53%**
  **8**    WHI II Premarin \[25\]                                    5310                                 **50--79**     **7.1**         **104**                     **1.96%**
  **8**    WHI II Placebo \[25\]                                     5429                                 **50--79**     **7.1**         **133**                     **2.45%**
  **9**    Sweden: The Gothenburg Breast Screening Trial \[26\]      **51,611**                           **39--59**     **14**          **1509**                    **2.92%**
  **10**   UK Trial of Early Detection of Breast Cancer \[10\]       **39,773**                           **45--64**     **7**           **459**                     **1.15%**
  **11**   Australia Record Review of Postmenopausal Women \[27\]    **508**                              **35--84**     **5.8**         **7**                       **1.38%**
  **12**   Osteoporosis Fracture Study \[28\]                        **9704**                             **\>65**       **3.2**         **117**                     **1.21%**
  **13**   Italy ORDET \[29\]                                        **4040**                             **40--69**     **3.5**         **25**                      **0.62%**
  **14**   NYU Postmenopausal \[30\]                                 **7063**                             **35--65**     **5.5**         **121**                     **1.71%**
  **15**   US Breast Cancer Demonstration Detection Program \[31\]   **283,222**                          **40--93**     **3.5**         **4275**                    **1.51%**
  **16**   Sweden-Malmo \[32\]                                       **42,283**                           **45--69**     **25**          **2316**                    **5.47%**
  **17**   Norwegian Cohorts \[33\]                                  **229,256**                          **50--64**     **6**           **3997**                    **1.74%**
  **18**   Swedish Two-Country Trial: Active Screened Group \[34\]   **77,052**                           **40--74**     **7**           **1398**                    **1.81%**
  **19**   Canadian National Breast Screening Study \[35\]           **89,434**                           **40--59**     **7**           **1332**                    **1.49%**
           Total Numbers                                             **2,305,427**                                                       **34,514**                  
           **Mean Breast Cancer Incidence Calculation**              **34,514/2,205.427 ------------→**   **1.50%**                                                  
